Publicacións (49) Publicacións nas que participase algún/ha investigador/a

2024

  1. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

  3. Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  4. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

2023

  1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

    Thrombosis Update, Vol. 13

  2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

  3. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

    Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255

  4. Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial

    JAMA Network Open, Vol. 6, Núm. 4, pp. E237243

  5. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations

    British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981

  6. Morphological Hallmarks of Classical Fabry Disease: An Ultrastructural Study in a Large Spanish Family

    Journal of Clinical Medicine, Vol. 12, Núm. 17

  7. Risk for recurrence of symptomatic upper-extremity deep vein thrombosis in patients without cancer: Analysis of three RIETE cohorts

    Vascular Medicine (United Kingdom), Vol. 28, Núm. 4, pp. 324-330

  8. Screening for late-onset Pompe disease in Internal Medicine departments in Spain

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

  9. The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

  10. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 10, pp. 2811-2823

2022

  1. Budd-Chiari syndrome: epidemiological and clinical characteristics of a case series in Northwest Spain

    Egyptian Liver Journal, Vol. 12, Núm. 1

  2. Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  3. Survey on the management of Pompe disease in routine clinical practice in Spain

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

  4. The hazard of combining anticoagulants with antiplatelets in patients with venous thromboembolism: Findings from the RIETE registry

    Thrombosis Research

2021

  1. Enfermedad de Gaucher: una enfermedad multisistémica

    Galicia Clínica, Vol. 82, Núm. 1, pp. 18-22

  2. Perfil de pacientes con enfermedades minoritarias en Galicia. Perspectiva desde la medicina interna

    Galicia Clínica, Vol. 82, Núm. 1, pp. 9-14